Voxelotor, which can help reduce need for blood transfusions, is administered as a daily tablet
- sicklecellsuffolk
top of page
Search
Recent Posts
See AllThe MHRA (The Medicines and Healthcare products Regulatory Agency) approved the safety of this treatment in November 2023, offering hope and optimism to the sickle cell community. But on the 14th Marc
bottom of page